The research team projects that the Immuno-oncology Therapy market size will grow from XXX in 2024 to XXX by 2029, at an estimated CAGR of XX. The base year considered for the study is 2023, and the market size is projected from 2024 to 2029.
The prime objective of this report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries. Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts. The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.
By Market Players:
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda
BioNTech SE
Allogene Therapeutics
IMAB-I-Mab Biopharma Co.
Ltd.
Arcus Biosciences
Gritstone Oncology
Autolus Therapeutics
Rubius Therapeutics
By Type
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
By Application
Hospitals
Ambulatory Surgical Center
Others
By Regions/Countries:
North America
United States
Canada
Mexico
East Asia
China
Japan
South Korea
Europe
Germany
United Kingdom
France
Italy
Russia
Spain
Netherlands
Switzerland
Poland
South Asia
India
Pakistan
Bangladesh
Southeast Asia
Indonesia
Thailand
Singapore
Malaysia
Philippines
Vietnam
Myanmar
Middle East
Turkey
Saudi Arabia
Iran
United Arab Emirates
Israel
Iraq
Qatar
Kuwait
Oman
Africa
Nigeria
South Africa
Egypt
Algeria
Morocoo
Oceania
Australia
New Zealand
South America
Brazil
Argentina
Colombia
Chile
Venezuela
Peru
Puerto Rico
Ecuador
Rest of the World
Kazakhstan
Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Immuno-oncology Therapy 2018-2023, and development forecast 2024-2029 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend by types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2020.
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2018-2023 & Sales by Product Types.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2024-2029. Further the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.
Market Analysis by Product Type: The report covers majority Product Types in the Immuno-oncology Therapy Industry, including its product specifcations by each key player, volume, sales by Volume and Value (M USD).
Markat Analysis by Application Type: Based on the Immuno-oncology Therapy Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report will provide with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
COVID-19 Impact
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Immuno-oncology Therapy market in 2023. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Immuno-oncology Therapy Revenue
1.4 Market Analysis by Type
1.4.1 Global Immuno-oncology Therapy Market Size Growth Rate by Type: 2024 VS 2029
1.4.2 Monoclonal Antibodies
1.4.3 Immune Checkpoint Inhibitors
1.4.4 Immune System Modulators
1.4.5 Cancer Vaccines
1.5 Market by Application
1.5.1 Global Immuno-oncology Therapy Market Share by Application: 2024-2029
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Center
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Immuno-oncology Therapy Market
1.8.1 Global Immuno-oncology Therapy Market Status and Outlook (2018-2029)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
1.9 Global Market Growth Prospects
1.9.1 Global Immuno-oncology Therapy Revenue Estimates and Forecasts (2018-2029)
1.9.2 Global Immuno-oncology Therapy Production Capacity Estimates and Forecasts (2018-2029)
1.9.3 Global Immuno-oncology Therapy Production Estimates and Forecasts (2018-2029)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material
2.2 Manufacturing Cost Structure Analysis of Immuno-oncology Therapy
2.3 Manufacturing Process Analysis of Immuno-oncology Therapy
2.4 Industry Chain Structure of Immuno-oncology Therapy
3 Development and Manufacturing Plants Analysis of Immuno-oncology Therapy
3.1 Top Manufacturers Headquarters, Rank by Immuno-oncology Therapy Production
3.2 Global Immuno-oncology Therapy Manufacturing Plants Distribution and Commercial Production Date
4 Market Competition by Manufacturers
4.1 Global Immuno-oncology Therapy Production Capacity Market Share by Manufacturers (2018-2023)
4.2 Global Immuno-oncology Therapy Revenue Market Share by Manufacturers (2018-2023)
4.3 Global Immuno-oncology Therapy Average Price by Manufacturers (2018-2023)
4.4 Manufacturers Immuno-oncology Therapy Production Sites, Area Served, Product Type
5 Immuno-oncology Therapy Regional Market Analysis
5.1 Immuno-oncology Therapy Production by Regions
5.1.1 Global Immuno-oncology Therapy Production by Regions (2018-2023)
5.1.2 Global Immuno-oncology Therapy Revenue by Regions
5.2 Immuno-oncology Therapy Consumption by Regions
5.3 North America Immuno-oncology Therapy Market Analysis
5.3.1 North America Immuno-oncology Therapy Production
5.3.2 North America Immuno-oncology Therapy Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Immuno-oncology Therapy Import and Export
5.4 East Asia Immuno-oncology Therapy Market Analysis
5.4.1 East Asia Immuno-oncology Therapy Production
5.4.2 East Asia Immuno-oncology Therapy Revenue
5.4.3 Key Manufacturers in East Asia
5.4.4 East Asia Immuno-oncology Therapy Import & Export
5.5 Europe Immuno-oncology Therapy Market Analysis
5.5.1 Europe Immuno-oncology Therapy Production
5.5.2 Europe Immuno-oncology Therapy Revenue
5.5.3 Key Manufacturers in Europe
5.5.4 Europe Immuno-oncology Therapy Import & Export
5.6 South Asia Immuno-oncology Therapy Market Analysis
5.6.1 South Asia Immuno-oncology Therapy Production
5.6.2 South Asia Immuno-oncology Therapy Revenue
5.6.3 Key Manufacturers in South Asia
5.6.4 South Asia Immuno-oncology Therapy Import & Export
5.7 Southeast Asia Immuno-oncology Therapy Market Analysis
5.7.1 Southeast Asia Immuno-oncology Therapy Production
5.7.2 Southeast Asia Immuno-oncology Therapy Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Immuno-oncology Therapy Import & Export
5.8 Middle East Immuno-oncology Therapy Market Analysis
5.8.1 Middle East Immuno-oncology Therapy Production
5.8.2 Middle East Immuno-oncology Therapy Revenue
5.8.3 Key Manufacturers in Middle East
5.8.4 Middle East Immuno-oncology Therapy Import & Export
5.9 Africa Immuno-oncology Therapy Market Analysis
5.9.1 Africa Immuno-oncology Therapy Production
5.9.2 Africa Immuno-oncology Therapy Revenue
5.9.3 Key Manufacturers in Africa
5.9.4 Africa Immuno-oncology Therapy Import & Export
5.10 Oceania Immuno-oncology Therapy Market Analysis
5.10.1 Oceania Immuno-oncology Therapy Production
5.10.2 Oceania Immuno-oncology Therapy Revenue
5.10.3 Key Manufacturers in Oceania
5.10.4 Oceania Immuno-oncology Therapy Import & Export
5.11 South America Immuno-oncology Therapy Market Analysis
5.11.1 South America Immuno-oncology Therapy Production
5.11.2 South America Immuno-oncology Therapy Revenue
5.11.3 Key Manufacturers in South America
5.11.4 South America Immuno-oncology Therapy Import & Export
6 Immuno-oncology Therapy Sales Market by Type (2018-2029)
6.1 Global Immuno-oncology Therapy Historic Market Size by Type (2018-2023)
6.2 Global Immuno-oncology Therapy Forecasted Market Size by Type (2024-2029)
7 Immuno-oncology Therapy Consumption Market by Application(2018-2029)
7.1 Global Immuno-oncology Therapy Historic Market Size by Application (2018-2023)
7.2 Global Immuno-oncology Therapy Forecasted Market Size by Application (2024-2029)
8 Company Profiles and Key Figures in Immuno-oncology Therapy Business
8.1 Amgen
8.1.1 Amgen Company Profile
8.1.2 Amgen Immuno-oncology Therapy Product Specification
8.1.3 Amgen Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.2 AstraZeneca
8.2.1 AstraZeneca Company Profile
8.2.2 AstraZeneca Immuno-oncology Therapy Product Specification
8.2.3 AstraZeneca Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.3 Bristol-Myers Squibb
8.3.1 Bristol-Myers Squibb Company Profile
8.3.2 Bristol-Myers Squibb Immuno-oncology Therapy Product Specification
8.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.4 Eli-Lilly
8.4.1 Eli-Lilly Company Profile
8.4.2 Eli-Lilly Immuno-oncology Therapy Product Specification
8.4.3 Eli-Lilly Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.5 Roche
8.5.1 Roche Company Profile
8.5.2 Roche Immuno-oncology Therapy Product Specification
8.5.3 Roche Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.6 GlaxoSmithKline
8.6.1 GlaxoSmithKline Company Profile
8.6.2 GlaxoSmithKline Immuno-oncology Therapy Product Specification
8.6.3 GlaxoSmithKline Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.7 Janssen Biotech
8.7.1 Janssen Biotech Company Profile
8.7.2 Janssen Biotech Immuno-oncology Therapy Product Specification
8.7.3 Janssen Biotech Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.8 Merck
8.8.1 Merck Company Profile
8.8.2 Merck Immuno-oncology Therapy Product Specification
8.8.3 Merck Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.9 Novartis
8.9.1 Novartis Company Profile
8.9.2 Novartis Immuno-oncology Therapy Product Specification
8.9.3 Novartis Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.10 Pfizer
8.10.1 Pfizer Company Profile
8.10.2 Pfizer Immuno-oncology Therapy Product Specification
8.10.3 Pfizer Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.11 Sanofi
8.11.1 Sanofi Company Profile
8.11.2 Sanofi Immuno-oncology Therapy Product Specification
8.11.3 Sanofi Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.12 Spectrum Pharmaceuticals
8.12.1 Spectrum Pharmaceuticals Company Profile
8.12.2 Spectrum Pharmaceuticals Immuno-oncology Therapy Product Specification
8.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.13 Takeda
8.13.1 Takeda Company Profile
8.13.2 Takeda Immuno-oncology Therapy Product Specification
8.13.3 Takeda Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.14 BioNTech SE
8.14.1 BioNTech SE Company Profile
8.14.2 BioNTech SE Immuno-oncology Therapy Product Specification
8.14.3 BioNTech SE Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.15 Allogene Therapeutics
8.15.1 Allogene Therapeutics Company Profile
8.15.2 Allogene Therapeutics Immuno-oncology Therapy Product Specification
8.15.3 Allogene Therapeutics Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.16 IMAB-I-Mab Biopharma Co.
8.16.1 IMAB-I-Mab Biopharma Co. Company Profile
8.16.2 IMAB-I-Mab Biopharma Co. Immuno-oncology Therapy Product Specification
8.16.3 IMAB-I-Mab Biopharma Co. Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.17 Ltd.
8.17.1 Ltd. Company Profile
8.17.2 Ltd. Immuno-oncology Therapy Product Specification
8.17.3 Ltd. Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.18 Arcus Biosciences
8.18.1 Arcus Biosciences Company Profile
8.18.2 Arcus Biosciences Immuno-oncology Therapy Product Specification
8.18.3 Arcus Biosciences Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.19 Gritstone Oncology
8.19.1 Gritstone Oncology Company Profile
8.19.2 Gritstone Oncology Immuno-oncology Therapy Product Specification
8.19.3 Gritstone Oncology Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.20 Autolus Therapeutics
8.20.1 Autolus Therapeutics Company Profile
8.20.2 Autolus Therapeutics Immuno-oncology Therapy Product Specification
8.20.3 Autolus Therapeutics Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
8.21 Rubius Therapeutics
8.21.1 Rubius Therapeutics Company Profile
8.21.2 Rubius Therapeutics Immuno-oncology Therapy Product Specification
8.21.3 Rubius Therapeutics Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
9 Production and Supply Forecast
9.1 Global Forecasted Production of Immuno-oncology Therapy (2024-2029)
9.2 Global Forecasted Revenue of Immuno-oncology Therapy (2024-2029)
9.3 Global Forecasted Price of Immuno-oncology Therapy (2018-2029)
9.4 Global Forecasted Production of Immuno-oncology Therapy by Region (2024-2029)
9.4.1 North America Immuno-oncology Therapy Production, Revenue Forecast (2024-2029)
9.4.2 East Asia Immuno-oncology Therapy Production, Revenue Forecast (2024-2029)
9.4.3 Europe Immuno-oncology Therapy Production, Revenue Forecast (2024-2029)
9.4.4 South Asia Immuno-oncology Therapy Production, Revenue Forecast (2024-2029)
9.4.5 Southeast Asia Immuno-oncology Therapy Production, Revenue Forecast (2024-2029)
9.4.6 Middle East Immuno-oncology Therapy Production, Revenue Forecast (2024-2029)
9.4.7 Africa Immuno-oncology Therapy Production, Revenue Forecast (2024-2029)
9.4.8 Oceania Immuno-oncology Therapy Production, Revenue Forecast (2024-2029)
9.4.9 South America Immuno-oncology Therapy Production, Revenue Forecast (2024-2029)
9.4.10 Rest of the World Immuno-oncology Therapy Production, Revenue Forecast (2024-2029)
9.5 Forecast by Type and by Application (2024-2029)
9.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2024-2029)
9.5.2 Global Forecasted Consumption of Immuno-oncology Therapy by Application (2024-2029)
10 Consumption and Demand Forecast
10.1 North America Forecasted Consumption of Immuno-oncology Therapy by Country
10.2 East Asia Market Forecasted Consumption of Immuno-oncology Therapy by Country
10.3 Europe Market Forecasted Consumption of Immuno-oncology Therapy by Countriy
10.4 South Asia Forecasted Consumption of Immuno-oncology Therapy by Country
10.5 Southeast Asia Forecasted Consumption of Immuno-oncology Therapy by Country
10.6 Middle East Forecasted Consumption of Immuno-oncology Therapy by Country
10.7 Africa Forecasted Consumption of Immuno-oncology Therapy by Country
10.8 Oceania Forecasted Consumption of Immuno-oncology Therapy by Country
10.9 South America Forecasted Consumption of Immuno-oncology Therapy by Country
10.10 Rest of the world Forecasted Consumption of Immuno-oncology Therapy by Country
11 Marketing Channel, Distributors and Customers
11.1 Marketing Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
12 Market Dynamics
12.1 Market Trends
12.2 Opportunities and Drivers
12.3 Challenges
12.4 Porter's Five Forces Analysis
13 Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
Key Players Covered: Ranking by Immuno-oncology Therapy Revenue 2018-2023
Global Immuno-oncology Therapy Market Size by Type: 2024-2029
Global Immuno-oncology Therapy Market Size by Application: 2024-2029
Immuno-oncology Therapy Production Rank and Commercial Production Date of Key Manufacturers
Global Immuno-oncology Therapy Manufacturing Plants Distribution and Commercial Production Date
Global Immuno-oncology Therapy Production Capacity by Manufacturers
Global Immuno-oncology Therapy Production by Manufacturers (2018-2023)
Global Immuno-oncology Therapy Production Market Share by Manufacturers (2018-2023)
Global Immuno-oncology Therapy Revenue by Manufacturers (2018-2023)
Global Immuno-oncology Therapy Revenue Share by Manufacturers (2018-2023)
Global Market Immuno-oncology Therapy Average Price of Key Manufacturers (2018-2023)
Manufacturers Immuno-oncology Therapy Production Sites and Area Served
Manufacturers Immuno-oncology Therapy Product Type
Global Immuno-oncology Therapy Production by Regions (2018-2023)
Global Immuno-oncology Therapy Production Market Share by Regions (2018-2023)
Global Immuno-oncology Therapy Revenue by Regions (2018-2023)
Global Immuno-oncology Therapy Revenue Market Share by Regions (2018-2023)
Global Immuno-oncology Therapy Consumption by Regions (2018-2023)
Global Immuno-oncology Therapy Consumption Market Share by Regions (2018-2023)
Key Immuno-oncology Therapy Players Sales Volume in North America
North America Immuno-oncology Therapy Production, Consumption Import and Export
Key Immuno-oncology Therapy Players Sales Volume in East Asia
East Asia Immuno-oncology Therapy Production, Consumption Import and Export
Key Immuno-oncology Therapy Players Sales Volume in Europe
Europe Immuno-oncology Therapy Production, Consumption Import and Export
Key Immuno-oncology Therapy Players Sales Volume in South Asia
South Asia Immuno-oncology Therapy Production, Consumption Import and Export
Key Immuno-oncology Therapy Players Sales Volume in Southeast Asia
Southeast Asia Immuno-oncology Therapy Production, Consumption Import and Export
Key Immuno-oncology Therapy Players Sales Volume in Middle East
Middle East Immuno-oncology Therapy Production, Consumption Import and Export
Key Immuno-oncology Therapy Players Sales Volume in Africa
Africa Immuno-oncology Therapy Production, Consumption Import and Export
Key Immuno-oncology Therapy Players Sales Volume in Oceania
Oceania Immuno-oncology Therapy Production, Consumption Import and Export
Key Immuno-oncology Therapy Players Sales Volume in South America
South America Immuno-oncology Therapy Production, Consumption Import and Export
Global Immuno-oncology Therapy Market Size by Type (2018-2023)
Global Immuno-oncology Therapy Revenue Market Share by Type (2018-2023)
Global Immuno-oncology Therapy Forecasted Market Size by Type (2024-2029)
Global Immuno-oncology Therapy Revenue Market Share by Type (2024-2029)
Global Immuno-oncology Therapy Market Size by Application (2018-2023)
Global Immuno-oncology Therapy Revenue Market Share by Application (2018-2023)
Global Immuno-oncology Therapy Forecasted Market Size by Application (2024-2029)
Global Immuno-oncology Therapy Revenue Market Share by Application (2024-2029)
Amgen Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
AstraZeneca Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
Bristol-Myers Squibb Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
Table Eli-Lilly Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
Roche Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
GlaxoSmithKline Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
Janssen Biotech Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
Merck Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
Novartis Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
Pfizer Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
Sanofi Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
Spectrum Pharmaceuticals Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
Takeda Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
BioNTech SE Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
Allogene Therapeutics Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
IMAB-I-Mab Biopharma Co. Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
Ltd. Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
Arcus Biosciences Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
Gritstone Oncology Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
Autolus Therapeutics Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
Rubius Therapeutics Immuno-oncology Therapy Production Capacity, Revenue, Price and Gross Margin (2018-2023)
Global Immuno-oncology Therapy Production Forecast by Region (2024-2029)
Global Immuno-oncology Therapy Sales Volume Forecast by Type (2024-2029)
Global Immuno-oncology Therapy Sales Volume Market Share Forecast by Type (2024-2029)
Global Immuno-oncology Therapy Sales Revenue Forecast by Type (2024-2029)
Global Immuno-oncology Therapy Sales Revenue Market Share Forecast by Type (2024-2029)
Global Immuno-oncology Therapy Sales Price Forecast by Type (2024-2029)
Global Immuno-oncology Therapy Consumption Volume Forecast by Application (2024-2029)
Global Immuno-oncology Therapy Consumption Value Forecast by Application (2024-2029)
North America Immuno-oncology Therapy Consumption Forecast 2024-2029 by Country
East Asia Immuno-oncology Therapy Consumption Forecast 2024-2029 by Country
Europe Immuno-oncology Therapy Consumption Forecast 2024-2029 by Country
South Asia Immuno-oncology Therapy Consumption Forecast 2024-2029 by Country
Southeast Asia Immuno-oncology Therapy Consumption Forecast 2024-2029 by Country
Middle East Immuno-oncology Therapy Consumption Forecast 2024-2029 by Country
Africa Immuno-oncology Therapy Consumption Forecast 2024-2029 by Country
Oceania Immuno-oncology Therapy Consumption Forecast 2024-2029 by Country
South America Immuno-oncology Therapy Consumption Forecast 2024-2029 by Country
Rest of the world Immuno-oncology Therapy Consumption Forecast 2024-2029 by Country
Market Key Trends
Key Opportunities and Drivers: Impact Analysis (2024-2029)
Key Challenges
Research Programs/Design for This Report
Key Data Information from Secondary Sources
Key Data Information from Primary Sources
Global Immuno-oncology Therapy Market Share by Type: 2023 VS 2029
Monoclonal Antibodies Features
Immune Checkpoint Inhibitors Features
Immune System Modulators Features
Cancer Vaccines Features
Global Immuno-oncology Therapy Market Share by Application: 2023 VS 2029
Hospitals Case Studies
Ambulatory Surgical Center Case Studies
Others Case Studies
Immuno-oncology Therapy Report Years Considered
Global Immuno-oncology Therapy Market Status and Outlook (2018-2029)
North America Immuno-oncology Therapy Revenue (Value) and Growth Rate (2018-2029)
East Asia Immuno-oncology Therapy Revenue (Value) and Growth Rate (2018-2029)
Europe Immuno-oncology Therapy Revenue (Value) and Growth Rate (2018-2029)
South Asia Immuno-oncology Therapy Revenue (Value) and Growth Rate (2018-2029)
South America Immuno-oncology Therapy Revenue (Value) and Growth Rate (2018-2029)
Middle East Immuno-oncology Therapy Revenue (Value) and Growth Rate (2018-2029)
Africa Immuno-oncology Therapy Revenue (Value) and Growth Rate (2018-2029)
Oceania Immuno-oncology Therapy Revenue (Value) and Growth Rate (2018-2029)
South America Immuno-oncology Therapy Revenue (Value) and Growth Rate (2018-2029)
Rest of the World Immuno-oncology Therapy Revenue (Value) and Growth Rate (2018-2029)
Global Immuno-oncology Therapy Revenue (2018-2029)
Global Immuno-oncology Therapy Production Capacity (2018-2029)
Global Immuno-oncology Therapy Production (2018-2029)
Manufacturing Cost Structure Analysis of Immuno-oncology Therapy in 2023
Manufacturing Process Analysis of Immuno-oncology Therapy
Industry Chain Structure of Immuno-oncology Therapy
Global Immuno-oncology Therapy Production Market Share by Regions in 2023
Global Immuno-oncology Therapy Revenue Market Share by Regions in 2023
North America Immuno-oncology Therapy Production Growth Rate 2018-2023
North America Immuno-oncology Therapy Revenue Growth Rate 2018-2023
East Asia Immuno-oncology Therapy Production Growth Rate 2018-2023
East Asia Immuno-oncology Therapy Revenue Growth Rate 2018-2023
Europe Immuno-oncology Therapy Production Growth Rate 2018-2023
Europe Immuno-oncology Therapy Revenue Growth Rate 2018-2023
South Asia Immuno-oncology Therapy Production Growth Rate 2018-2023
South Asia Immuno-oncology Therapy Revenue Growth Rate 2018-2023
Southeast Asia Immuno-oncology Therapy Production Growth Rate 2018-2023
Southeast Asia Immuno-oncology Therapy Revenue Growth Rate 2018-2023
Middle East Immuno-oncology Therapy Production Growth Rate 2018-2023
Middle East Immuno-oncology Therapy Revenue Growth Rate 2018-2023
Africa Immuno-oncology Therapy Production Growth Rate 2018-2023
Africa Immuno-oncology Therapy Revenue Growth Rate 2018-2023
Oceania Immuno-oncology Therapy Production Growth Rate 2018-2023
Oceania Immuno-oncology Therapy Revenue Growth Rate 2018-2023
South America Immuno-oncology Therapy Production Growth Rate 2018-2023
South America Immuno-oncology Therapy Revenue Growth Rate 2018-2023
Amgen Immuno-oncology Therapy Product Specification
AstraZeneca Immuno-oncology Therapy Product Specification
Bristol-Myers Squibb Immuno-oncology Therapy Product Specification
Eli-Lilly Immuno-oncology Therapy Product Specification
Roche Immuno-oncology Therapy Product Specification
GlaxoSmithKline Immuno-oncology Therapy Product Specification
Janssen Biotech Immuno-oncology Therapy Product Specification
Merck Immuno-oncology Therapy Product Specification
Novartis Immuno-oncology Therapy Product Specification
Pfizer Immuno-oncology Therapy Product Specification
Sanofi Immuno-oncology Therapy Product Specification
Spectrum Pharmaceuticals Immuno-oncology Therapy Product Specification
Takeda Immuno-oncology Therapy Product Specification
BioNTech SE Immuno-oncology Therapy Product Specification
Allogene Therapeutics Immuno-oncology Therapy Product Specification
IMAB-I-Mab Biopharma Co. Immuno-oncology Therapy Product Specification
Ltd. Immuno-oncology Therapy Product Specification
Arcus Biosciences Immuno-oncology Therapy Product Specification
Gritstone Oncology Immuno-oncology Therapy Product Specification
Autolus Therapeutics Immuno-oncology Therapy Product Specification
Rubius Therapeutics Immuno-oncology Therapy Product Specification
Global Immuno-oncology Therapy Production Capacity Growth Rate Forecast (2024-2029)
Global Immuno-oncology Therapy Revenue Growth Rate Forecast (2024-2029)
Global Immuno-oncology Therapy Price and Trend Forecast (2018-2029)
North America Immuno-oncology Therapy Production Growth Rate Forecast (2024-2029)
North America Immuno-oncology Therapy Revenue Growth Rate Forecast (2024-2029)
East Asia Immuno-oncology Therapy Production Growth Rate Forecast (2024-2029)
East Asia Immuno-oncology Therapy Revenue Growth Rate Forecast (2024-2029)
Europe Immuno-oncology Therapy Production Growth Rate Forecast (2024-2029)
Europe Immuno-oncology Therapy Revenue Growth Rate Forecast (2024-2029)
South Asia Immuno-oncology Therapy Production Growth Rate Forecast (2024-2029)
South Asia Immuno-oncology Therapy Revenue Growth Rate Forecast (2024-2029)
Southeast Asia Immuno-oncology Therapy Production Growth Rate Forecast (2024-2029)
Southeast Asia Immuno-oncology Therapy Revenue Growth Rate Forecast (2024-2029)
Middle East Immuno-oncology Therapy Production Growth Rate Forecast (2024-2029)
Middle East Immuno-oncology Therapy Revenue Growth Rate Forecast (2024-2029)
Africa Immuno-oncology Therapy Production Growth Rate Forecast (2024-2029)
Africa Immuno-oncology Therapy Revenue Growth Rate Forecast (2024-2029)
Oceania Immuno-oncology Therapy Production Growth Rate Forecast (2024-2029)
Oceania Immuno-oncology Therapy Revenue Growth Rate Forecast (2024-2029)
South America Immuno-oncology Therapy Production Growth Rate Forecast (2024-2029)
South America Immuno-oncology Therapy Revenue Growth Rate Forecast (2024-2029)
Rest of the World Immuno-oncology Therapy Production Growth Rate Forecast (2024-2029)
Rest of the World Immuno-oncology Therapy Revenue Growth Rate Forecast (2024-2029)
North America Immuno-oncology Therapy Consumption Forecast 2024-2029
East Asia Immuno-oncology Therapy Consumption Forecast 2024-2029
Europe Immuno-oncology Therapy Consumption Forecast 2024-2029
South Asia Immuno-oncology Therapy Consumption Forecast 2024-2029
Southeast Asia Immuno-oncology Therapy Consumption Forecast 2024-2029
Middle East Immuno-oncology Therapy Consumption Forecast 2024-2029
Africa Immuno-oncology Therapy Consumption Forecast 2024-2029
Oceania Immuno-oncology Therapy Consumption Forecast 2024-2029
South America Immuno-oncology Therapy Consumption Forecast 2024-2029
Rest of the world Immuno-oncology Therapy Consumption Forecast 2024-2029
Channels of Distribution
Porter's Five Forces Analysis
Key Executives Interviewed
Publisher: HNY Research
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support